Overview of the treatment of heart failure

Keyphrases

• Heart Failure 100%
• Heart Failure Treatment 100%
• Exercise Tolerance 66%
• Quality of Life 66%
• Diuretics 66%
• Hydralazine 66%
• Digoxin 66%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 66%
• Nitrate 33%
• Vasodilator 33%
• Therapeutic Advances 33%
• Symptom Relief 33%
• Congestive Heart Failure 33%
• Beta-blockers 33%
• Drug Effects 33%
• Hospitalization 33%
• Left Ventricular Dysfunction 33%
• Heart Failure Management 33%
• Left Ventricular Ejection Fraction 33%
• Life Expectancy 33%
• Improved Survival 33%
• Patient Mortality 33%
• Isosorbide Dinitrate 33%
• Neurohormonal 33%
• Shortness of Breath 33%
• Patient Morbidity 33%
• Ventricular Remodeling 33%
• Lower Extremity Edema 33%
• Mortality Reduction 33%
• Cardiac Structural Abnormality 33%
• Positive Inotropes 33%
• Far Left 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Congestive Heart Failure 100%
• Dipeptidyl Carboxypeptidase Inhibitor 33%
• Digoxin 33%
• Diuretics 33%
• Hydralazine 16%
• Heart Ventricle Remodeling 16%
• Life Expectancy 16%
• Heart Left Ventricle Failure 16%
• Nitric Acid Derivative 16%
• Inotropic Agent 16%
• Hydralazine Plus Isosorbide Dinitrate 16%
• Dyspnea 16%
• Edema 16%